RADIOLABELED MONOCLONAL ANTIBODY THERAPY, FLUDARABINE PHOSPHATE, AND LOW-DOSE TOTAL-BODY IRRADIATION FOLLOWED BY DONOR STEM CELL TRANSPLANT AND IMMUNOSUPPRESSION THERAPY IN TREATING OLDER PATIENTS WITH ADVANCED ACUTE MYELOID LEUKEMIA OR HIGH-RISK MYELODYSPLASTIC SYNDROMES: